HtrA protease family as therapeutic targets

Joanna Skórko-Glonek , Dorota Żurawa-Janicka , Tomasz Koper , Mirosław Jarząb , Donata Figaj , Przemysław Glaza , Barbara Lipińska


Author Joanna Skórko-Glonek (FB / DB)
Joanna Skórko-Glonek,,
- Department of Biochemistry
, Dorota Żurawa-Janicka (FB / DB)
Dorota Żurawa-Janicka,,
- Department of Biochemistry
, Tomasz Koper (FB)
Tomasz Koper,,
- Faculty of Biology
, Mirosław Jarząb (FB / DB)
Mirosław Jarząb,,
- Department of Biochemistry
, Donata Figaj (FB / DB)
Donata Figaj,,
- Department of Biochemistry
, Przemysław Glaza (FB / DB)
Przemysław Glaza,,
- Department of Biochemistry
, Barbara Lipińska (FB / DB)
Barbara Lipińska,,
- Department of Biochemistry
Journal seriesCurrent Pharmaceutical Design, ISSN 1381-6128, (A 35 pkt)
Issue year2013
Publication size in sheets1.6
Keywords in EnglishHtrA of pathogenic bacteria, E. coli HtrA, HtrA in cancer, HtrA in neurodegenerative diseases, HtrA activity regulation, HtrA and cell death, HtrA targeting
ASJC Classification3002 Drug Discovery; 3004 Pharmacology
Languageen angielski
Score (nominal)35
ScoreMinisterial score = 35.0, 24-07-2019, ArticleFromJournal
Ministerial score (2013-2016) = 35.0, 24-07-2019, ArticleFromJournal
Publication indicators Scopus SNIP (Source Normalised Impact per Paper): 2013 = 0.99; WoS Impact Factor: 2013 = 3.288 (2) - 2013=3.555 (5)
Citation count*
Share Share

Get link to the record

* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.